These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 5063870)
41. [Rationale for prescribing oral contraceptives]. Teichmann AT Wien Med Wochenschr; 1998; 148(7):171-4. PubMed ID: 9700865 [TBL] [Abstract][Full Text] [Related]
42. [Influence of oral contraceptives on the nasal mucosa]. Ammar-Kohdja A Rev Laryngol Otol Rhinol (Bord); 1971; 92(1):40-2. PubMed ID: 5574270 [No Abstract] [Full Text] [Related]
43. [Arterial hypertension during treatment with estro-progestative agents]. Dumont M; Pellissier B; Laforet J; Dick D J Med Lyon; 1971 Mar; 52(204):381-3. PubMed ID: 5135329 [No Abstract] [Full Text] [Related]
44. Topics in clinical medicine. The liver and oral contraceptives. Hartley RA; Boitnott JK; Iber FL Johns Hopkins Med J; 1969 Feb; 124(2):112-8. PubMed ID: 5766380 [No Abstract] [Full Text] [Related]
45. Oral contraceptives and periodontal health. Perry DA J West Soc Periodontol Periodontal Abstr; 1981; 29(3):72-80. PubMed ID: 6242875 [No Abstract] [Full Text] [Related]
46. [Hormonal contraceptives--psychosomatic aspects]. Maass G Z Allgemeinmed; 1973 Sep; 49(27):1291-4. PubMed ID: 4757762 [No Abstract] [Full Text] [Related]
47. [Studies on drug diabetes. Abnormal carbohydrate metabolism caused by oral contraceptive agents]. Ishigami R; Shiotani S; Yoshida A; Kawata T; Natori H Naika Hokan; 1968 Jan; 15(1):11-5. PubMed ID: 5690963 [No Abstract] [Full Text] [Related]
53. Physiologic and pharmacologic effects of estrogen and progestins on bone. DeCherney A J Reprod Med; 1993 Dec; 38(12 Suppl):1007-14. PubMed ID: 8120857 [TBL] [Abstract][Full Text] [Related]
54. Growth of leiomyomata with estrogen--progestogen therapy. John AH; Martin R J Reprod Med; 1971 Feb; 6(2):56-8. PubMed ID: 5115282 [No Abstract] [Full Text] [Related]
55. [Choice of ovulation inhibitors]. Mall-Haefeli M Ther Umsch; 1970 Oct; 27(10):652-9. PubMed ID: 5512723 [No Abstract] [Full Text] [Related]
56. [Various possible adverse effects of synthetic estroprogestinic preparations at the extragenital level (review of the literature and personal contributions)]. Lauro V Arch Ostet Ginecol; 1969; 74(3):193-235. PubMed ID: 5402696 [No Abstract] [Full Text] [Related]
57. Hypertension and oral contraception. Smith RW Trans Pac Coast Obstet Gynecol Soc; 1971; 39(0):50-5. PubMed ID: 5164822 [No Abstract] [Full Text] [Related]
58. Strokes in young women using oral contraceptives. Cole M Arch Intern Med; 1967 Nov; 120(5):551-5. PubMed ID: 6054589 [No Abstract] [Full Text] [Related]
59. Oral contraceptive agents and the glucose tolerance problem. Cohn RE Pa Med; 1971 Jan; 74(1):62-4. PubMed ID: 5540284 [No Abstract] [Full Text] [Related]
60. Breast cancer and progestogens. Paulshock BZ JAMA; 1968 Apr; 204(1):82. PubMed ID: 5694308 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]